Multiple sclerosis

Disability and mortality in a cohort of clinically diagnosed patients

A. Citterio, G. Azan, R. Bergamaschi, A. Erbetta, V. Cosi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

A sample of hospitalized MS patients was selected according to clinical and demographic criteria with the aim of establishing prognostic factors. The sample included 52 patients with first hospitalization from 1 January, 1975, to 31 December, 1976. At follow-up after 12 years a malignant course was observed in 33 patients (death in 13, severe disability in 20 patients). The malignant course was related to age at onset (3=35 years) and higher disability, progressive course and cerebellar symptoms at onset. One half of patients with a reiapsing-remitting course entered into a progressive phase of the disease after a mean duration of 7.3 years.

Original languageEnglish
Pages (from-to)249-253
Number of pages5
JournalNeuroepidemiology
Volume8
Issue number5
DOIs
Publication statusPublished - 1989

Fingerprint

Multiple Sclerosis
Mortality
Age of Onset
Hospitalization
Demography

Keywords

  • Disability
  • Mortality
  • Multiple sclerosis

ASJC Scopus subject areas

  • Epidemiology
  • Clinical Neurology

Cite this

Multiple sclerosis : Disability and mortality in a cohort of clinically diagnosed patients. / Citterio, A.; Azan, G.; Bergamaschi, R.; Erbetta, A.; Cosi, V.

In: Neuroepidemiology, Vol. 8, No. 5, 1989, p. 249-253.

Research output: Contribution to journalArticle

@article{673b1ebb9b4844b68ed92dff820807c3,
title = "Multiple sclerosis: Disability and mortality in a cohort of clinically diagnosed patients",
abstract = "A sample of hospitalized MS patients was selected according to clinical and demographic criteria with the aim of establishing prognostic factors. The sample included 52 patients with first hospitalization from 1 January, 1975, to 31 December, 1976. At follow-up after 12 years a malignant course was observed in 33 patients (death in 13, severe disability in 20 patients). The malignant course was related to age at onset (3=35 years) and higher disability, progressive course and cerebellar symptoms at onset. One half of patients with a reiapsing-remitting course entered into a progressive phase of the disease after a mean duration of 7.3 years.",
keywords = "Disability, Mortality, Multiple sclerosis",
author = "A. Citterio and G. Azan and R. Bergamaschi and A. Erbetta and V. Cosi",
year = "1989",
doi = "10.1159/000110190",
language = "English",
volume = "8",
pages = "249--253",
journal = "Neuroepidemiology",
issn = "0251-5350",
publisher = "S. Karger AG",
number = "5",

}

TY - JOUR

T1 - Multiple sclerosis

T2 - Disability and mortality in a cohort of clinically diagnosed patients

AU - Citterio, A.

AU - Azan, G.

AU - Bergamaschi, R.

AU - Erbetta, A.

AU - Cosi, V.

PY - 1989

Y1 - 1989

N2 - A sample of hospitalized MS patients was selected according to clinical and demographic criteria with the aim of establishing prognostic factors. The sample included 52 patients with first hospitalization from 1 January, 1975, to 31 December, 1976. At follow-up after 12 years a malignant course was observed in 33 patients (death in 13, severe disability in 20 patients). The malignant course was related to age at onset (3=35 years) and higher disability, progressive course and cerebellar symptoms at onset. One half of patients with a reiapsing-remitting course entered into a progressive phase of the disease after a mean duration of 7.3 years.

AB - A sample of hospitalized MS patients was selected according to clinical and demographic criteria with the aim of establishing prognostic factors. The sample included 52 patients with first hospitalization from 1 January, 1975, to 31 December, 1976. At follow-up after 12 years a malignant course was observed in 33 patients (death in 13, severe disability in 20 patients). The malignant course was related to age at onset (3=35 years) and higher disability, progressive course and cerebellar symptoms at onset. One half of patients with a reiapsing-remitting course entered into a progressive phase of the disease after a mean duration of 7.3 years.

KW - Disability

KW - Mortality

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=0024445996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024445996&partnerID=8YFLogxK

U2 - 10.1159/000110190

DO - 10.1159/000110190

M3 - Article

VL - 8

SP - 249

EP - 253

JO - Neuroepidemiology

JF - Neuroepidemiology

SN - 0251-5350

IS - 5

ER -